The management of mucosal leishmaniasis in immunocompromised patients is not standardized and limited data are available on the use of miltefosine for treatment and secondary prophylaxis. We describe a case of mucosal leishmaniasis in an HIV-coinfected patient treated with miltefosine due to a severe allergic reaction to liposomal amphotericin B.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
mucosal leishmaniasis
12
miltefosine patient
4
patient mucosal
4
leishmaniasis hiv-coinfection
4
hiv-coinfection challenge
4
challenge long-term
4
long-term management
4
management management
4
management mucosal
4
leishmaniasis immunocompromised
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!